PROBLEMS OF INTERPRETATION OF SERUM CONCENTRATIONS OF ALPHA-FETOPROTEIN (AFP) IN PATIENTS RECEIVING CYTO-TOXIC CHEMOTHERAPY FOR MALIGNANT GERM-CELL TUMORS

被引：22

作者：

COPPACK, S ^{[1
]}

NEWLANDS, ES ^{[1
]}

DENT, J ^{[1
]}

MITCHELL, H ^{[1
]}

GOKA, G ^{[1
]}

BAGSHAWE, KD ^{[1
]}

机构：

[1] CHARING CROSS HOSP,DEPT MED ONCOL,LONDON W6 8RF,ENGLAND

来源：

关键词：

D O I：

10.1038/bjc.1983.197

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：335 / 340

页数：6

共 24 条

[11] KURMAN RJ, 1977, CANCER-AM CANCER SOC, V40, P2136, DOI 10.1002/1097-0142(197711)40:5<2136::AID-CNCR2820400524>3.0.CO
[12] 2-D
[13] OCCURRENCE OF FETOPROTEIN IN PATIENTS WITH NEOPLASMS AND NON-NEOPLASTICS DISEASES
MASOPUST, J
KITHIER, K
RADL, J
KOUTECKY, J
KOTAL, L
[J]. INTERNATIONAL JOURNAL OF CANCER, 1968, 3 (03) : 364 - +
[14] MCINTIRE KR, 1972, CANCER RES, V32, P1941
[15] CHEMOTHERAPY OF ADVANCED MALIGNANT TERATOMAS
NEWLANDS, ES
BEGENT, RHJ
KAYE, SB
RUSTIN, GJS
BAGSHAWE, KD
[J]. BRITISH JOURNAL OF CANCER, 1980, 42 (03) : 378 - 384
[16] NEWLANDS ES, 1982, CANCER CHEMOTH PHARM, V7, P211
[17] NEWLANDS ES, 1983, LANCET, V1, P948
[18] NORGAARDPEDERSEN B, 1975, ACTA PATH MICRO IM A, V83, P573
[19] ALPHA-FETOPROTEIN-LIKE ACTIVITY IN SERA FROM PATIENTS WITH MALIGNANT AND NON-MALIGNANT DISEASE AND HEALTHY INDIVIDUALS
NORGAARDPEDERSEN, B
AXELSEN, NH
[J]. CLINICA CHIMICA ACTA, 1976, 71 (02) : 343 - 347
[20] TESTICULAR CANCER - ROLE OF BIOLOGICAL TUMOR-MARKERS
PEARSON, JC
SPAULDING, JT
FRIEDMAN, MA
[J]. CANCER TREATMENT REVIEWS, 1979, 6 (04) : 217 - 221